CS
ZYME icon

Candriam SCA’s Zymeworks ZYME Stock Holding History

Candriam SCA’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-120,305
Closed -$946K – 940
2022
Q4 		$946K Buy
+120,305
New +$845K 0.01% 703
2021
Q3 		– Sell
-473,124
Closed -$16.4M – 917
2021
Q2 		$16.4M Buy
473,124
+111,583
+31% +$3.54M 0.11% 212
2021
Q1 		$16.4M Buy
361,541
+2
+0% +$81 0.14% 169
2020
Q4 		$17.1M Sell
361,539
-260,521
-42% -$12.1M 0.14% 170
2020
Q3 		$29M Buy
622,060
+277,576
+81% +$9.53M 0.27% 86
2020
Q2 		$12.4M Buy
344,484
+112,215
+48% +$4.13M 0.13% 184
2020
Q1 		$10.3M Buy
232,269
+14
+0% +$573 0.11% 207
2019
Q4 		$10.6M Buy
+232,255
New +$8.44M 0.11% 209

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Candriam SCA's ZYME Position: Q1 2023 in Review

Candriam SCA sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 120,305 shares — an estimated $946K sold.

Candriam SCA first reported a position in ZYME in Q4 2019 and held it in 8 quarters. The position peaked at $29M in Q3 2020. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.

  • Candriam SCA reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
  • Candriam SCA sold 120,305 Zymeworks shares in Q1 2023, an estimated $946K.
  • Candriam SCA first reported a position in Zymeworks in Q4 2019 and held it in 8 quarters.
  • Candriam SCA's Zymeworks position peaked at $29M in Q3 2020.
  • 115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.